Scientists at UC San Francisco have developed a revolutionary cancer treatment that precisely targets tumors with radiation ...

A new review highlights SETDB1 as a key player in osteosarcoma, promoting tumor growth, immune evasion and therapy resistance ...

Researchers from the School of Engineering and Applied Science and the Perelman School of Medicine, along with the Children's ...

For four decades, Ohio State blood and bone marrow transplant innovation has improved cancer care with an increasing emphasis ...

Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk ...

Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, ...